Pharmaceutical compliance support in the United States
Lokale Regeln, verbunden mit Ihrem globalen Modell.
Eunomia helps pharmaceutical and biotech teams plan US compliance operations, connecting federal and state requirements with review, engagement, monitoring and reporting workflows.
For international pharma teams preparing US commercial activity, emerging biotechs building compliance processes and compliance leaders coordinating multiple states, products and third parties.
Die praktische Herausforderung: United States
US requirements span federal law, FDA rules, programme integrity, transparency reporting, industry commitments and state laws. A national SOP may miss state-specific reporting, marketing-code or HCP interaction requirements.
Von der Anforderung zur Umsetzung
Wie Eunomia helfen kann
We can map planned activities to applicable requirements, identify state-specific questions for legal review and translate agreed controls into SOPs, approval routes and monitoring. Support can include promotional review coordination, HCP engagement and payment workflows, reporting checks, training and automation. Eunomia identifies Karen Glade as its Global Compliance Business Partner for the United States and Canada; confirm scope and specialist support before engagement.
Auslegung lokaler Kodizes und Beantwortung von Anfragen
02
Prüfung der Zusammenarbeit mit Angehörigen der Gesundheitsberufe und Patientenorganisationen
03
Lokale Transparenz- und Offenlegungspflichten
04
Prüfung von Werbe- und Nicht-Werbematerialien
05
Compliance-Bewertung für den Markteintritt
06
Bewertung von Fach- und Sprachanforderungen
Ihr Nutzen
Anforderungen (United States) in Ihre globalen Prozesse integriert
Klare Zuständigkeiten für Prüfung und Eskalation
Lokale Unterstützung ohne unnötigen Fixkostenaufbau
Die Regeln: United States
Was die Compliance prägt: United States…
Ein kurzer Überblick über die wichtigsten gesetzlichen und selbstregulatorischen Regelwerke. Jede Zusammenfassung verweist unten auf die offizielle Quelle.
FDA prescription drug promotion
FDA rules require advertising to be truthful and non-misleading, with risk information in fair balance with benefit claims. Claims must be consistent with approved labeling and supported by appropriate evidence. Build review, reference checks, version control and applicable submissions into the workflow.
Consumer health claims
FTC guidance requires health-related advertising claims to be truthful, not misleading and adequately substantiated before dissemination. Review campaign net impression, including digital content, testimonials and implied claims, and retain supporting evidence.
Federal HCP arrangements
The federal Anti-Kickback Statute prohibits knowingly and willfully offering, paying, soliciting or receiving remuneration to induce or reward referrals involving items or services payable by a federal healthcare programme. Assess arrangements on their facts; written terms, legitimate need, appropriate compensation and evidence of services are useful controls. Obtain legal advice where required.
Open Payments
Applicable manufacturers and group purchasing organisations report specified payments to covered recipients and certain physician ownership interests through CMS Open Payments. Applicability depends on statutory definitions. Build recipient validation, reconciliation, correction, attestation and records into the annual process; CMS thresholds change each year.
Industry codes and state requirements
The PhRMA Code is an industry commitment for companies that adopt it, not a federal statute. States may add conduct, registration, training, audit or disclosure obligations. Massachusetts, for example, requires covered manufacturers to register, follow its marketing code, train relevant staff, conduct annual audits and submit reports. Maintain a state-by-state assessment.
Diese Übersicht dient ausschließlich der Information und stellt keine Rechtsberatung dar. Geltungsbereich und Anwendung sind für das jeweilige Unternehmen, den Markt, die Tätigkeit und die Gegenpartei zu bestätigen. Quellen geprüft im September 2026.
Fragen und Antworten
Pharma-Compliance: United States: häufige Fragen
Does FDA pre-approve every US promotional material?
No. FDA says pre-approval is generally not required, subject to limited exceptions and specific requirements. Companies remain responsible for compliant content and applicable submissions.
Does one federal process cover every state?
No. States may impose additional conduct, registration, training, audit or disclosure rules. Assess states where the company, agents and activities operate.
Does Eunomia have a US office or formal regulatory representative?
This guide does not claim a US office or formal regulatory appointment. Eunomia identifies Karen Glade as its Global Compliance Business Partner for the United States and Canada. Contact us to confirm expertise and delivery arrangements.
Sagen Sie uns, was auf Ihrem Schreibtisch liegt.
Wir hören zu, stellen einige Fragen und empfehlen den passenden Umfang – unverbindlich und ohne Druck.